Skip to content
The Policy VaultThe Policy Vault

Xarelto — Medical Mutual

Atrial Fibrillation, Nonvalvular (or Atrial Flutter)

Reauthorization criteria

  • Response to therapy is required for continuation unless otherwise noted

Approval duration

2 years